Market Exclusive

Bio-Techne Corp (NASDAQ:TECH) reported earnings of $0.90 per share beating Walls Streets expectations.

Bio-Techne Corp (NASDAQ:TECH) reported Q1 2018 earnings this Morning, coming in at $0.90 per share, beating Wall Street’s estimates of $0.88 per Share. Revenue for the quarter came in at $144.61 million beating analyst estimates of $142.37 million

Analyst Coverage For Bio-Techne Corp (NASDAQ:TECH)
These are 2 Hold Ratings, 3 Buy Ratings .
The current consensus rating for Bio-Techne Corp (NASDAQ:TECH) is Buy (Score: 2.60) with a consensus target price of $123.00 , a potential (0.62% downside)Recent Insider Trading for Bio-Techne Corp (NASDAQ:TECH)

Dividend History for Bio-Techne Corp (NASDAQ:TECH)

Recent Trading for Bio-Techne Corp (NASDAQ:TECH) Shares of Bio-Techne Corp closed the previous trading session at with shares trading hands.

Exit mobile version